| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/04/2002 | WO2002051301A2 Fullerene (c60)-based x-ray contrast agent for diagnostic imaging |
| 07/04/2002 | US20020087071 Process for graphic visualization and diagnosis of thrombi by means of nuclear spin tomography with use of particulate contrast media |
| 07/04/2002 | US20020086978 Specific binding agents |
| 07/04/2002 | US20020086865 Use of growth hormone secretagogues for stimulating or increasing appetite |
| 07/04/2002 | US20020086814 Selectively killing cells via targeting fragment of a toxin or lectin with photosensitizing agent, then exposing to light/radiation |
| 07/04/2002 | US20020086290 Method for determining the prognosis of a patient with a neurological disease |
| 07/04/2002 | DE10065482A1 New heavier halogen atom substituted squarane dyes, used as photosensitizer in photodynamic therapeutical applications, fluorescent detector of tumors and sensitizer in water sterilization |
| 07/04/2002 | DE10065068A1 Mehrstufen-Verfahren zur Herstellung von gasgefüllten Mikrokapseln mit definiert enger Größenverteilung durch definierte Fremdbegasung während des Mikrokapselaufbaus Multi-stage process for the production of gas-filled microcapsules with a narrow size distribution defined by defined external gassing during the microcapsule structure |
| 07/03/2002 | EP1219307A2 Stable radioiodine conjugates and methods for their synthesis |
| 07/03/2002 | EP1218496A2 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 07/03/2002 | EP1218037A2 In vivo assay for testing the phenotypic stability |
| 07/03/2002 | EP1217993A2 Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 07/03/2002 | CN1357111A Process |
| 07/03/2002 | CN1356913A Vitronectic receptor antagonist pharmaceuticals |
| 07/02/2002 | US6414139 Silicon amphiphilic compounds and the use thereof |
| 07/02/2002 | US6413770 NL4 tie ligand homologue nucleic acid |
| 07/02/2002 | US6413511 Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide |
| 07/02/2002 | CA2040204C Chelating compounds and their use |
| 07/02/2002 | CA2038493C 1,4,7,10-tetraazacyclododecane butyltriols |
| 06/27/2002 | WO2002049752A2 Multi-step method for producing gas-filled microcapsules |
| 06/27/2002 | WO2002049422A2 Non-human animal disease models |
| 06/27/2002 | WO2002020822A3 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 06/27/2002 | WO2002015881A3 Use of a porous carrier |
| 06/27/2002 | WO2001054680A3 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 06/27/2002 | US20020083478 Immune defective rodents; for use ae animal model in the treatment of human prostate cancer |
| 06/27/2002 | US20020082517 Tissue marking using biocompatible microparticles |
| 06/27/2002 | DE10061195A1 Verwendung von Abformmassen zur Herstellung von Behandlungsvorrichtungen Use of impression materials for the production of treatment devices |
| 06/26/2002 | EP1216060A2 Magnetic nanoparticles having biochemical activity, method for the production thereof and their use |
| 06/26/2002 | EP0896547B1 Diagnostic composition |
| 06/26/2002 | EP0752889B1 Liposomes containing a x-ray- or ultrasound contrast agent |
| 06/26/2002 | EP0464147B1 Matrix metalloproteinase inhibitor peptides |
| 06/26/2002 | CN1355790A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isindoline derivatives |
| 06/26/2002 | CN1355705A Method of identifying therapeutic compounds for treatment of hepatic disorders |
| 06/25/2002 | US6410824 Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
| 06/25/2002 | US6410695 Individual medicament dosing conjugate |
| 06/25/2002 | US6410339 Detecting defect of metabolism; obtain human, administer cortisol agonist, monitor cortisol generation, classify metabolic defect |
| 06/25/2002 | US6410314 Episomally replicating vector, its preparation and use |
| 06/25/2002 | US6409990 Backbone comprising dextran having affixed thereto a plurality of groups having amino-alkyl-thio-alkyl-ether structure |
| 06/25/2002 | US6409989 A free-flowing suspension of activated carbon particles ground and graded to <50 mu; antiagglomerants; grinding in a cylindrical rod mill in a chamber coated with a nonabrasive lining; accuracy |
| 06/25/2002 | US6409671 Ultrasonography |
| 06/25/2002 | CA2245462C Methods of modulating cell proliferation through telomerase modulation |
| 06/25/2002 | CA2135648C Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 06/20/2002 | WO2002048119A2 Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof |
| 06/20/2002 | WO2002047680A2 Use of tocopherol, metabolites or derivatives thereof or flavonoid metabolites or derivatives thereof in the manufacture of a medicament for the treatment of tissue ischemia |
| 06/20/2002 | WO2002047537A2 Compositions and methods for in situ and in vivo imaging of cells and tissues |
| 06/20/2002 | WO2002032375A3 Uses of monoclonal antibody 8h9 |
| 06/20/2002 | WO2002031202A3 High throughput genetic screening of lipid and cholesterol processing using fluorescent compounds |
| 06/20/2002 | WO2001095795A3 Optical imaging of induced signals in vivo under ambient light conditions |
| 06/20/2002 | WO2001054771A3 Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 06/20/2002 | US20020076380 Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use |
| 06/20/2002 | US20020076378 Radically asymmetric dendrimeric polymer (polylactam) backbone linked to at least one reporter moiety; contrast agents which contain large amounts of metal per molecule |
| 06/20/2002 | CA2430415A1 Use of tocopherol, metabolites or derivatives thereof or flavonoid metabolites or derivatives thereof in the manufacture of a medicament for the treatment of tissue ischemia |
| 06/19/2002 | EP1214946A2 Compositions and method for MRI-imaging malignant tumors using carbon 13 |
| 06/19/2002 | EP1214586A2 Implantable glucose sensor |
| 06/19/2002 | EP1214101A1 Method for detecting and killing epithelial cancer cells |
| 06/19/2002 | EP1214100A2 Method for determining viability of a myocardial segment |
| 06/19/2002 | EP1214099A1 Antibody dye conjugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor peripheries |
| 06/19/2002 | EP1214079A1 Drug for treating fractures |
| 06/19/2002 | EP1214067A1 Methods for treating cell proliferative disorders including cancer |
| 06/19/2002 | EP1164838A4 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation |
| 06/19/2002 | EP0462215B1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS |
| 06/19/2002 | CN1354751A Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging |
| 06/18/2002 | US6407236 Tumor diagnosis; antiinflammatory agents; antiischemic agents; antidepressants |
| 06/18/2002 | US6407214 Engineering human antibodies |
| 06/18/2002 | US6407058 Phosphorylation of serine or threonine |
| 06/18/2002 | US6406917 Enhancing sensitivity of tumor cells in chemotherapy |
| 06/18/2002 | US6406693 Killing tumor vascular endothelial cells by treatment with antibodies and binding with antigens |
| 06/18/2002 | US6406680 X-ray contrast agents |
| 06/13/2002 | WO2002046418A2 Lipid-associated molecules |
| 06/13/2002 | WO2002046385A2 Enzymes |
| 06/13/2002 | WO2002046230A2 G-protein coupled receptors |
| 06/13/2002 | WO2002046147A2 Perturbed membrane-binding compounds |
| 06/13/2002 | WO2002046139A2 1,7 and 1,9-diarylpolymethine salts |
| 06/13/2002 | WO2002045661A1 Use of moulding compounds for producing treatment devices |
| 06/13/2002 | WO2002045590A1 Method for regional administeration of preparations for curing liver tumors |
| 06/13/2002 | WO2002028441A3 Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits |
| 06/13/2002 | WO2002013874A8 Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses |
| 06/13/2002 | WO2002012339A3 Sequences for integrin alpha-8 |
| 06/13/2002 | WO2001082899A3 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
| 06/13/2002 | WO2000066741A3 Conserved neisserial antigens |
| 06/13/2002 | US20020072667 Magnetic resonance imaging |
| 06/13/2002 | US20020071843 Targeted therapeutic agents |
| 06/13/2002 | US20020071808 Method for imaging malignant tumors using carbon 13 with MRI |
| 06/13/2002 | US20020069650 A system for generating low temperature refrigeration for use such as cooling superconducting cable wherein a neon based refrigerant fluid is work expanded by a sealed turboexpander/ loader to generate refrigeration which is used to cool heat |
| 06/13/2002 | CA2436601A1 Perturbed membrane-binding compounds |
| 06/13/2002 | CA2430993A1 G-protein coupled receptors |
| 06/13/2002 | CA2428390A1 Enzymes |
| 06/13/2002 | CA2428208A1 Lipid-associated molecules |
| 06/12/2002 | EP1212941A2 Modulating ramp activity |
| 06/12/2002 | EP1212619A1 Substrates and screening methods for transport proteins |
| 06/12/2002 | EP1212600A1 Methylene blue diagnostic agent and diagnostic methods for detection of epithelial cancer |
| 06/12/2002 | EP1212103A1 4-fluoroalkyl-3-halophenyl nortropanes |
| 06/12/2002 | EP1212102A2 Method of tumor imaging |
| 06/12/2002 | EP1212101A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 06/12/2002 | EP1056474B1 Affinity markers for human serum albumin |
| 06/12/2002 | EP1005391B1 Process and apparatus for preparation of vesicles |
| 06/12/2002 | EP0876158B1 Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms |
| 06/11/2002 | US6405070 Detection of cancer using cellular autofluorescence |
| 06/11/2002 | US6405069 Time-resolved optoacoustic method and system for noninvasive monitoring of glucose |
| 06/11/2002 | US6403625 2(7-(1,3-dihydro-1,1-dimethyl-3-ethylbenz(e)indolin-2-ylidene) -1,3,5-heptatrienyl)-1,1-dimethyl-3-((6-((1,3-thiazolidine-2-t hion)-1-yl)-6-oxo)hexyl)-1h-benz(e)indolium chloride; stains proteins for cancer identification |